STAT
JANUARY 25, 2024
A historic new study out of Scotland shows the real-world impact of vaccines against the human papillomavirus: The country has detected no cases of cervical cancer in women born between 1988-1996 who were fully vaccinated against HPV between the ages of 12 and 13. Many previous studies have shown that HPV vaccines are extremely effective in preventing cervical cancer.
PharmaVoice
JANUARY 24, 2024
Executives on the healthcare giant’s full-year earnings call highlighted a strong cash position and incremental dealmaking as a way to get past incoming competition.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
ALiEM - Pharm Pearls
JANUARY 26, 2024
An 88-year-old female presented to the ER with a chief complaint of cough, vague abdominal pain, and a rash. The patient stated that she was started on Cipro eyedrops 1 or 2 days prior to presentation for a possible eye infection. A day prior to presentation she developed a purple purpuric rash on her lower extremities that gradually progressed up her legs, and was present on her buttocks thighs, and lower legs.
The Pharmacist
JANUARY 24, 2024
EXCLUSIVE: With the launch of Pharmacy First in England just days away, an under-pressure community pharmacy sector is torn between welcoming the opportunity and wondering whether patient demand will exceed its capacity. From 31 January, the launch of the highly anticipated service will see patients able to access advice and treatment for seven common conditions […] The post Pharmacy First: Are the floodgates about to open?
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
JANUARY 24, 2024
You’ve heard of long Covid, a condition in which the acute infection subsides but troubling symptoms persist. Less well known is chronic Covid: The virus just doesn’t leave, sometimes staying in patients’ bodies long enough to mutate into new variants. This happens to people whose immune systems are compromised, whether through disease or treatment, leaving them vulnerable to infections that last weeks, months, or, in one known case, a year.
PharmaVoice
JANUARY 23, 2024
What started as an examination of the Human Foods Program has expanded into an agency-wide overhaul.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
The Pharmacist
JANUARY 22, 2024
Community pharmacies are among the 'most likely' places to encounter a case of measles, NHS England (NHSE) has warned. And staff have been instructed to 'take appropriate action' and wear personal protective equipment (PPE) to 'stop onward transmission without delay', when dealing with patients with suspected measles. This comes as the UK Health Security Agency […] The post Wear PPE for suspected measles, pharmacies told appeared first on The Pharmacist.
STAT
JANUARY 21, 2024
LONDON — Starting Monday, a new, highly effective malaria vaccine will be rolled out for the first time, as an immunization campaign for children kicks off in Cameroon — a day that global health officials say marked a historic step in the decades-long quest to protect people from one of the world’s deadliest infections. The vaccine drive in Cameroon — the first launch of the vaccine outside of clinical trials and pilot programs — comes as some 20 African countr
EMCrit Project
JANUARY 22, 2024
background: ANTHARTIC trial Prophylaxis against VAP (ventilator associated pneumonia) has is already supported by a few studies in the literature, perhaps most notably the ANTHARTIC trial. That was a multi-center RCT evaluating 48 hours of therapy with ampicillin-sulbactam for patients intubated following cardiac arrest. Antibiotic therapy reduced early-onset VAP, with a trend towards more ventilator-free […] EMCrit Project by Josh Farkas.
Pharmaceutical Commerce
JANUARY 26, 2024
Concerns regarding hypoglycemia potentially linked to a counterfeit version of Ozempic come at a time in which reports have grown regarding the improper use of GLP-1 receptor agonists for the purpose of cosmetic weight loss.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The Pharmacist
JANUARY 25, 2024
Community pharmacies that have ordered but not yet received an otoscope may begin offering the Pharmacy First service from 31 January without the otitis media clinical pathway. This comes in response to reports of pharmacy owners struggling to get hold of otoscopes, The Pharmacist understands. NHS England (NHSE) made the concession in a letter to pharmacy contractors […] The post Pharmacies can start Pharmacy First without an otoscope, says NHSE appeared first on The Pharmacist.
STAT
JANUARY 22, 2024
America is over the Covid vaccine. Frantic lineups for scarce doses when Covid vaccines first became available have long since given way to widespread indifference. Each new round of boosters has drawn fewer bared arms than the round before it. The Centers for Disease Control and Prevention estimates that, as of Jan. 6, a mere 21.5% of Americans aged 18 and older and 11% of children have been vaccinated with the latest Covid vaccine.
BioPharma Dive
JANUARY 24, 2024
An 11-year-old boy born deaf can hear after receiving Lilly's genetic medicine. Others, including biotechs in China and Regeneron in the U.S., are taking aim at the same drug target.
Drug Patent Watch
JANUARY 22, 2024
A recent article published in Health Affairs, delves into the Federal Trade Commission’s (FTC) concerns regarding the inclusion of improper patents in the FDA’s Orange Book by pharmaceutical manufacturers. The… The post Legislative Proposals to Tackle Improper Pharmaceutical Patents in the Orange Book appeared first on DrugPatentWatch - Make Better Decisions.
The Pharmacist
JANUARY 22, 2024
Almost nine in 10 employed and locum pharmacists are concerned over the potential damage Pharmacy First may have on an ‘already fragile’ workforce in England, a survey by the Pharmacists’ Defence Association (PDA) has revealed. ‘Many’ among the more than 3,500 staff surveyed also said they were worried the ‘hurried’ upcoming service launch could put […] The post Pharmacists concerned Pharmacy First will raise risk of patient abuse appeared first on The Pharmacist.
STAT
JANUARY 24, 2024
If you want an argument in favor of teaching the humanities, I suggest you ask a medical educator. Across the U.S., the age-old debate about the value of a liberal arts education has seemingly devolved into mortal combat, leaving the humanities in dire straits on college campuses. For example, the Atlantic recently reported on West Virginia University’s decision to gut its humanities programming, and the New York Times wondered whether the liberal arts will exist after the budget cuts hap
BioPharma Dive
JANUARY 22, 2024
New details of the proposed acquisitions show there were multiple interested buyers, which, according to some analysts, could set the stage for more dealmaking.
pharmaphorum
JANUARY 24, 2024
"The Omni Advantage: Accelerating the Behavioural Change with Omnichannel in Pharma Sales Engagement" is a game-changing book by businesswoman Merhnaz Campbell. Discover insights, strategies, and inspiration for pharma sales field team success.
The Pharmacist
JANUARY 23, 2024
Recommendations made to the parliamentary pharmacy inquiry include giving greater powers to non-prescribing pharmacists to vary prescriptions and freeing up pharmacists for a more clinical, patient-facing role. Speaking to the health and social care committee (HSCC) last week, the chief executive of the General Pharmaceutical Council (GPhC) suggested that changes needed to be made to […] The post Don’t forget clinical capacity of non-prescribers, urges GPhC appeared first on The Pharmacist
STAT
JANUARY 24, 2024
In the spring of 2020, my almost 4-year-old daughter Livie sustained a severe traumatic brain injury (TBI) when a tree branch fell on her head in our backyard, devastating our whole family. Returning home after five months in the hospital, the real journey began : How do we best care for and support our daughter, who cannot do any daily activities on her own, cannot walk or talk, and has become cognitively impaired?
Express Pharma
JANUARY 22, 2024
Novo Nordisk and Eli Lilly have been dominating the obesity scene in the past year with the approval of their glucagon-like peptide-1 receptor (GLP-1R) agonists Wegovy and Zepbound. Although medicines with other mechanisms of actions are available on the market, GLP-1R agonists seem to have a greater impact on weight loss and the patient’s life. The development of new weight loss medicines is therefore making great progress, but obesity care needs a much greater revolution, says GlobalData.
pharmaphorum
JANUARY 24, 2024
CG Oncology completes the first biotech IPO of 2024, raising $380 million for its oncolytic virus bladder cancer immunotherapy.
The Pharmacist
JANUARY 25, 2024
Understanding the responsibilities of a pharmacist employed under the Additional Roles Reimbursement Scheme and ensuring those in post are supported at work have been cited as recent challenges within primary care networks (PCNs) and practices. Here, Krupa Dave and Devinder Kalsi, lead medicines optimisation pharmacists at Central London Community Healthcare Trust (CLCH), share the structured workplan […] The post How PCNs can support pharmacists: guidance from a London trust appeared firs
STAT
JANUARY 25, 2024
WASHINGTON — Sen. Bernie Sanders on Thursday jabbed the CEO of Merck for telling congressional staff that he didn’t have the expertise to testify at a Senate hearing on prescription drug prices because he’s a tax attorney. Sanders, who has threatened to subpoena the CEOs of Merck and Johnson & Johnson over their refusal to testify at a hearing on why drug prices are higher in the United States than other countries, told reporters the reasons the companies gave ranged fro
BioPharma Dive
JANUARY 26, 2024
The opinion would allow Abecma to be prescribed after two standard therapies and is the latest sign of CAR-T’s growing use in earlier cancer treatment.
pharmaphorum
JANUARY 25, 2024
Discover the role of GenAI in life sciences in 2024. Explore how artificial intelligence and machine learning techniques like GenAI are revolutionising drug development, diagnostics, and research. Learn how industry leaders, including Google, are leveraging GenAI to advance healthcare and enhance patient outcomes.
The Pharmacist
JANUARY 24, 2024
More than half a million women in England have accessed hormone replacement therapy (HRT) via the HRT pre-payment certificate (PPC) since its introduction last spring, the government has announced. The PPC scheme was launched on 1 April 2023, reducing prescription costs for eligible HRT items to £19.30 a year. Calculations from the Department of Health […] The post Over 500,000 women have accessed HRT through pre-paid certificates appeared first on The Pharmacist.
STAT
JANUARY 23, 2024
The head of the Abortion Fund of Ohio had a sinking feeling as she looked at its end-of-year finances last month. The fund had paid out $1.5 million in 2023 to help close to 4,400 patients get abortions — up from 1,175 the year before — and the pace wasn’t sustainable. If the fund didn’t take a pause for a few weeks, she feared it would run out of money and have to close for good.
BioPharma Dive
JANUARY 22, 2024
Trodelvy didn’t outperform chemotherapy in a large study of people with a common lung tumor, a setback that sent company shares down by double digits.
The Guardian - Pharmaceutical Industry
JANUARY 25, 2024
Bloc plans to bulk-buy key drugs for all 27 countries, potentially leaving Britain ‘behind in the queue’ The EU is to stockpile key medicines that will worsen the record drug shortages in the UK, with experts warning that the country could be left “behind in the queue”. The EU is seeking to safeguard its supplies by switching to a system in which its 27 members work together to secure reliable supplies of 200 commonly used medications, such as antibiotics, painkillers and vaccines.
pharmaphorum
JANUARY 25, 2024
On today’s podcast, host Jonah Comstock is joined by Arturo Araya, EVP of commercialisation at Cellares, a company that is attempting to create a new kind of contract manufacturing organisation for the rapidly crystalizing world of cell and gene therapy.
STAT
JANUARY 25, 2024
Transgender women, in particular those belonging to marginalized racial and ethnic groups, have disproportionately high rates of HIV. Yet so far, no standardized surveillance system has collected data that could provide insight into the factors that put people at higher risk for contracting the virus. A survey of transgender women, developed by the Centers for Disease Control and Prevention, aimed to gather and assess behavioral data in relation to HIV prevention and risk for the first time.
Med Ed 101
JANUARY 21, 2024
There are so many inhalers on the market for asthma and COPD. LABA, LAMA, and ICS products are getting so hard to keep track of! Honestly, it gets a little overwhelming at times to remember them all by brand name and what category and classification they fall into. My good friend Derek Borkowski is the […] The post Inhaler Chart – Free PDF!
Pharmaceutical Business Review
JANUARY 25, 2024
The facility is designed to bolster in-house production of drug substances for Investigational New Drug (IND)-enabling studies and trials. This development is pivotal for the company’s proprietary and partnered programme pipelines. The 20,000ft 2 facility includes a lipid formulation production suite and additional suites for mRNA and plasmid DNA (pDNA) manufacturing.
The Pharmacist
JANUARY 24, 2024
A new plan aiming to shore up the UK’s supply of pharmaceuticals has been unveiled by the government. As part of the Department for Business and Trade’s (DBT’s) recently launched Critical Imports and Supply Chains Strategy, an online portal will be set up to allow importers of essential goods – including medicines and healthcare supplies […] The post New government strategy targets medicine supply chain disruption appeared first on The Pharmacist.
Expert insights. Personalized for you.
364 
Let's personalize your content